Geri A. Sawada - Concepedia

Author

Geri A. Sawada

Eli Lilly (United States)

Also Known As

G A Sawada, G Sawada, G. A. Sawada, G. Sawada, G.A. Sawada, Geri A. Sawada, Geri Sawada

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)W.E. Upjohn Institute for Employment Research University at Buffalo, State University of New York University of Rochester Medical Center University of Toronto

About

Geri A. Sawada is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	17	711
2	Biochemistry	6	6	271
3	Health Sciences	4	4	121
4	Natural Sciences	4	4	248
5	Biomedical Engineering	2	2	207

Geri A. Sawada

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Brain Exposure of Two Selective Dual CDK4 and CDK6 Inhibitors and the Antitumor Activity of CDK4 and CDK6 Inhibition in Combination with Temozolomide in an Intracranial Glioblastoma Xenograft Thomas J. Raub, Graham N. Wishart, Palaniappan Kulanthaivel, Drug Metabolism and Disposition	2015	270
Permeability of bovine brain microvessel endothelial cells in vitro: Barrier tightening by a factor released from astroglioma cells Thomas J. Raub, Sandra L. Kuentzel, Geri A. Sawada Experimental Cell Research AngiogenesisAstroglioma CellsVascular BiologyNeurologyBiomedical Engineering	1992	161
Pioglitazone preserves pancreatic islet structure and insulin secretory function in three murine models of type 2 diabetes A. R. Diani, Geri A. Sawada, B. M. Wyse, American Journal of Physiology-Endocrinology and Metabolism	2004	101
Integration of in Silico and in Vitro Tools for Scaffold Optimization during Drug Discovery: Predicting P-Glycoprotein Efflux Prashant Desai, Geri A. Sawada, Ian A. Watson, Molecular Pharmaceutics Pharmaceutical ResearchDrug TargetGlycobiologyMolecular BiologyDrug Discovery Process	2013	96
Rhodamine Inhibitors of P-Glycoprotein: An Amide/Thioamide “Switch” for ATPase Activity Michael K. Gannon, Jason J. Holt, Stephanie M. Bennett, Journal of Medicinal Chemistry	2009	71
Breast Cancer Resistance Protein Interacts with Various Compounds in Vitro, but Plays a Minor Role in Substrate Efflux at the Blood-Brain Barrier Rong Zhao, Thomas J. Raub, Geri A. Sawada, Drug Metabolism and Disposition	2009	71
Use of a Biophysical-Kinetic Model to Understand the Roles of Protein Binding and Membrane Partitioning on Passive Diffusion of Highly Lipophilic Molecules Across Cellular Barriers Thomas J. Raub, Craig L. Barsuhn, Lawrence R. Williams, Journal of drug targeting	1993	71
Increased Lipophilicity and Subsequent Cell Partitioning Decrease Passive Transcellular Diffusion of Novel, Highly Lipophilic Antioxidants Geri A. Sawada, Craig L. Barsuhn, Barry S. Lutzke, Journal of Pharmacology and Experimental Therapeutics	1999	69
Pyrrolopyrimidines: Novel Brain-Penetrating Antioxidants with Neuroprotective Activity in Brain Injury and Ischemia Models Edward D. Hall, Paula K. Andrus, Sarah L. Smith, Journal of Pharmacology and Experimental Therapeutics	1997	64
Selenorhodamine Photosensitizers for Photodynamic Therapy of P-Glycoprotein-Expressing Cancer Cells Jacqueline Hill, Michelle K. Linder, Kellie S. Davies, Journal of Medicinal Chemistry Medicinal ChemistryThioamide FunctionalitySupramolecular PhotochemistryPhotochemistryPhotodynamic Therapy	2014	63

Page 1